Global X Management Company’s Alexion Pharmaceuticals ALXN Stock Holding History

Global X Management Company’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$531K	Buy	4,280 +1,463	+52%	+$171K	0.01%	667
2018 Q1	$314K	Buy	2,817 +169	+6%	+$20.2K	0.01%	769
2017 Q4	$317K	Sell	2,648 -208	-7%	-$25.3K	0.01%	684
2017 Q3	$401K	Buy	2,856 +153	+6%	+$20.8K	0.01%	598
2017 Q2	$329K	Buy	2,703 +737	+37%	+$85.8K	0.01%	637
2017 Q1	$238K	Buy	1,966 +452	+30%	+$58.3K	0.01%	708
2016 Q4	$185K	Buy	1,514 +589	+64%	+$72.1K	0.01%	675
2016 Q3	$113K	Buy	925 +864	+1,416%	+$111K	0.01%	728
2016 Q2	$7K	Buy	+61	New	+$8.65K	﹤0.01%	912

Other funds holding ALXN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Global X Management Company's ALXN Position: Q2 2018 in Review

Global X Management Company increased its Alexion Pharmaceuticals (ALXN) stake by 52% in Q2 2018, buying an estimated $171K and bringing the position to 4,280 shares worth $531K. The position accounts for 0.01% of the portfolio, ranked #667.

Global X Management Company first reported a position in ALXN in Q2 2016 and has held it in 9 quarters since. 600 funds tracked by Wall St. Rank hold ALXN as of Q2 2018.

Global X Management Company held 4,280 shares of Alexion Pharmaceuticals worth $531K as of Q2 2018.
Global X Management Company bought 1,463 Alexion Pharmaceuticals shares in Q2 2018, an estimated $171K.
Alexion Pharmaceuticals made up 0.01% of Global X Management Company's portfolio in Q2 2018, its #667 holding.
Global X Management Company first reported a position in Alexion Pharmaceuticals in Q2 2016 and has held it in 9 quarters since.
600 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.